| Stage | CSL | % of rev | MSA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.5B | 100.00% | $503M | 100.00% | CSL ×2.91 |
| Gross profit | $495M | 33.82% | $249M | 49.53% | MSA +15.7pp |
| Operating income | $293M | 20.04% | $112M | 22.24% | MSA +2.2pp |
| Pre-tax income | $270M | 18.44% | $111M | 22.13% | MSA +3.7pp |
| Net income | $208M | 14.22% | $86M | 17.12% | MSA +2.9pp |
| Stage | CSL | MSA | Gap · A − B |
|---|---|---|---|
| Revenue | $1.5B100.00% | $503M100.00% | CSL ×2.91 |
| Gross profit | 33.82%$495M | 49.53%$249M | MSA +15.7pp |
| Operating income | 20.04%$293M | 22.24%$112M | MSA +2.2pp |
| Pre-tax income | 18.44%$270M | 22.13%$111M | MSA +3.7pp |
| Net income |
| 14.22%$208M |
| 17.12%$86M |
| MSA +2.9pp |
No shared counterparties.